查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1607169

基因编辑技术市场：按产品、技术、应用和最终用户划分 - 2025-2030 年全球预测

Gene Editing Technologies Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Antisense, CRISPR, Talen), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年基因编辑技术市值为51.2亿美元，预计2024年将达到57.3亿美元，复合年增长率为12.57%，到2030年将达到117.4亿美元。

基因编辑技术包含多种分子工具，可对生物体的 DNA 进行有针对性的修改，从而在各个领域提供变革潜力。这些技术的需求在于它们在对抗遗传疾病、改良农作物和增强生物技术过程方面的精确性和效率。其应用涵盖医疗保健、农业和工业生物技术。在医疗保健领域，基因编辑可望治疗遗传疾病、开发个人化医疗和推进再生医学。在农业中，这些技术有助于培育产量、抗病虫害和耐受不利条件的作物。另一方面，工业应用包括生质燃料生产和发酵过程。除了全球粮食安全挑战之外，需要先进治疗解决方案的遗传疾病和慢性病的流行也是作物改良进步的关键驱动力。合成生物学领域的快速成长将进一步推动对基因编辑工具的需求。透过对研究和合作的持续投资，利用 CRISPR 技术及其衍生，我们有机会突破治疗解决方案和作物工程的界限。然而，由于伦理问题、监管障碍和可能导致意外基因变化的脱靶效应等限制，这仍然是一个重大挑战。透过透明的相关人员沟通和强有力的道德框架解决公众和监管问题对于市场扩张至关重要。创新应着重于提高基因编辑工具的准确性和特异性，开发治疗应用的传输系统，以及扩展生物资讯学基础设施以更好地进行基因组资料分析。市场动态的特点是进展迅速，但由于潜在的生物政治争议，需要谨慎行事。这些技术是一个快速发展的研究和商业领域，永续成长需要策略伙伴关係、持续的研发投资和遵守道德标准。

主要市场统计
基准年[2023] 51.2亿美元
预计年份 [2024] 57.3亿美元
预测年份 [2030] 117.4亿美元
复合年增长率（%） 12.57%

市场动态：揭示快速发展的基因编辑技术市场的关键市场洞察

供需的动态交互作用正在改变基因编辑技术市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球遗传病患疾病率上升
    • 加大基因编辑研发投入
    • 基于 CRISPR 的工具的重大改进
  • 市场限制因素
    • 开发基因编辑技术成本高昂
  • 市场机会
    • 基因编辑技术的技术进步
    • 个性化医疗的趋势
  • 市场挑战
    • 道德问题和严格的法律规范

波特五力：驾驭基因编辑科技市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对基因编辑技术市场的影响

外部宏观环境因素在塑造基因编辑技术市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解基因编辑技术市场的竞争状况

基因编辑技术市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵基因编辑技术市场供应商绩效评估

FPNV定位矩阵是评估基因编辑技术市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划基因编辑技术市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，基因编辑技术市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球遗传疾病发生率正在上升
      • 加大基因编辑研发投入
      • 基于 CRISPR 的工具的重大改进
    • 抑制因素
      • 基因编辑技术开发成本高昂
    • 机会
      • 基因编辑技术的技术进步
      • 个性化医疗方法的趋势
    • 任务
      • 道德问题和严格的法规结构
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 基因编辑技术市场：透过提供

  • 试剂/耗材
  • 服务
  • 软体及系统

第七章 基因编辑技术市场：依技术分类

  • 反义
  • 更脆
  • 塔伦
  • 锌指核酸酶 (ZFN)

第八章基因编辑技术市场：依应用分类

  • 动物基因工程
  • 细胞株工程
  • 基因工程
  • 植物基因工程

第九章 基因编辑技术市场：依最终使用者分类

  • 学术和政府研究机构
  • 生物技术和製药公司
  • 合约调查机构

第十章 北美与南美基因编辑技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区基因编辑技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲基因编辑技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • AMS Biotechnology Ltd.
  • Beam Therapeutics Inc.
  • Caribou Biosciences, Inc.
  • Cellectis SA
  • Creative Biogene
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Ltd.
  • Inscripta, Inc.
  • Integrated DNA Technologies, Inc.
  • Intellia Therapeutics, Inc.
  • Lonza Group Ltd.
  • Mammoth Biosciences, Inc.
  • Merck Group
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • Precision BioSciences, Inc.
  • Sangamo Therapeutics, Inc.
  • Synthego Corporation
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-2E76C3E47FBE

The Gene Editing Technologies Market was valued at USD 5.12 billion in 2023, expected to reach USD 5.73 billion in 2024, and is projected to grow at a CAGR of 12.57%, to USD 11.74 billion by 2030.

Gene editing technologies encompass a range of molecular tools that enable targeted modifications to the DNA of organisms, offering transformative potential across various domains. The necessity of these technologies lies in their precision and efficiency in addressing genetic disorders, improving agricultural crops, and enhancing biotechnological processes. Applications span healthcare, agriculture, and industrial biotechnology. In healthcare, gene editing holds promise for curing genetic diseases, developing personalized medicine, and advancing regenerative medicine. In agriculture, these technologies facilitate the development of crops with improved yield, resistance to pests and diseases, and tolerance to adverse conditions. Meanwhile, industrial applications include biofuel production and fermentation processes. A critical growth driver is the increasing prevalence of genetic and chronic diseases necessitating advanced therapeutic solutions, alongside the global food security challenge propelling advancements in crop modification. The burgeoning field of synthetic biology further boosts demand for gene editing tools. Opportunities lie in leveraging CRISPR technology and its derivatives to push boundaries in therapeutic solutions and crop engineering, with continuous investments and partnerships in research. However, limitations include ethical concerns, regulatory hurdles, and potential off-target effects that may lead to unforeseen genetic changes, which remain a significant challenge. Addressing public and regulatory apprehensions through transparent stakeholder communication and robust ethical frameworks is vital for market expansion. Innovation should focus on refining precision and specificity of gene-editing tools, developing delivery systems for therapeutic applications, and expanding the bioinformatics infrastructure for better genomic data analysis. Market dynamics are characterized by rapid advancements but with caution due to potential biopolitical controversies. These technologies represent a burgeoning area of research and commercial interest, where strategic partnerships, continuous R&D investment, and adherence to ethical standards will be critical for sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 5.12 billion
Estimated Year [2024] USD 5.73 billion
Forecast Year [2030] USD 11.74 billion
CAGR (%) 12.57%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Editing Technologies Market

The Gene Editing Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of genetic disorders worldwide
    • Increasing investments for R&D in gene editing
    • Significant improvements in CRISPR-based tools
  • Market Restraints
    • High cost of development of gene editing technologies
  • Market Opportunities
    • Technological advancements in gene editing technologies
    • Inclination toward personalized medicine approach
  • Market Challenges
    • Ethical concerns and stringent regulatory framework

Porter's Five Forces: A Strategic Tool for Navigating the Gene Editing Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Editing Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Editing Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Editing Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Editing Technologies Market

A detailed market share analysis in the Gene Editing Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Editing Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Editing Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Editing Technologies Market

A strategic analysis of the Gene Editing Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Editing Technologies Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AMS Biotechnology Ltd., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis SA, Creative Biogene, CRISPR Therapeutics AG, Editas Medicine, Inc., GenScript Biotech Corporation, Horizon Discovery Ltd., Inscripta, Inc., Integrated DNA Technologies, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck Group, New England Biolabs, Inc., OriGene Technologies, Inc., Precision BioSciences, Inc., Sangamo Therapeutics, Inc., Synthego Corporation, Takara Bio Inc., Tecan Trading AG, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Gene Editing Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Reagents & Consumables, Services, and Software & Systems.
  • Based on Technology, market is studied across Antisense, CRISPR, Talen, and Zinc Finger Nucleases (ZFN).
  • Based on Application, market is studied across Animal Genetic Engineering, Cell Line Engineering, Genetic Engineering, and Plant Genetic Engineering.
  • Based on End User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of genetic disorders worldwide
      • 5.1.1.2. Increasing investments for R&D in gene editing
      • 5.1.1.3. Significant improvements in CRISPR-based tools
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of gene editing technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in gene editing technologies
      • 5.1.3.2. Inclination toward personalized medicine approach
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical concerns and stringent regulatory framework
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Editing Technologies Market, by Offering

  • 6.1. Introduction
  • 6.2. Reagents & Consumables
  • 6.3. Services
  • 6.4. Software & Systems

7. Gene Editing Technologies Market, by Technology

  • 7.1. Introduction
  • 7.2. Antisense
  • 7.3. CRISPR
  • 7.4. Talen
  • 7.5. Zinc Finger Nucleases (ZFN)

8. Gene Editing Technologies Market, by Application

  • 8.1. Introduction
  • 8.2. Animal Genetic Engineering
  • 8.3. Cell Line Engineering
  • 8.4. Genetic Engineering
  • 8.5. Plant Genetic Engineering

9. Gene Editing Technologies Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Government Research Institutes
  • 9.3. Biotechnology & Pharmaceutical Companies
  • 9.4. Contract Research Organizations

10. Americas Gene Editing Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Gene Editing Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Gene Editing Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. AMS Biotechnology Ltd.
  • 3. Beam Therapeutics Inc.
  • 4. Caribou Biosciences, Inc.
  • 5. Cellectis SA
  • 6. Creative Biogene
  • 7. CRISPR Therapeutics AG
  • 8. Editas Medicine, Inc.
  • 9. GenScript Biotech Corporation
  • 10. Horizon Discovery Ltd.
  • 11. Inscripta, Inc.
  • 12. Integrated DNA Technologies, Inc.
  • 13. Intellia Therapeutics, Inc.
  • 14. Lonza Group Ltd.
  • 15. Mammoth Biosciences, Inc.
  • 16. Merck Group
  • 17. New England Biolabs, Inc.
  • 18. OriGene Technologies, Inc.
  • 19. Precision BioSciences, Inc.
  • 20. Sangamo Therapeutics, Inc.
  • 21. Synthego Corporation
  • 22. Takara Bio Inc.
  • 23. Tecan Trading AG
  • 24. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GENE EDITING TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. GENE EDITING TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. GENE EDITING TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. GENE EDITING TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE EDITING TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE EDITING TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ANTISENSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TALEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ZINC FINGER NUCLEASES (ZFN), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. GENE EDITING TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. GENE EDITING TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023